
### [MONDO:0016345](http://purl.obolibrary.org/obo/MONDO_0016345)
**Label:** non-familial restrictive cardiomyopathy

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0019439](http://purl.obolibrary.org/obo/MONDO_0019439) (AA amyloidosis), [MONDO:0016356](http://purl.obolibrary.org/obo/MONDO_0016356) (diffuse cutaneous systemic sclerosis), [MONDO:0016359](http://purl.obolibrary.org/obo/MONDO_0016359) (limited systemic sclerosis), [MONDO:0017833](http://purl.obolibrary.org/obo/MONDO_0017833) (primary hypereosinophilic syndrome), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0018018](http://purl.obolibrary.org/obo/MONDO_0018018) (wild type ATTR amyloidosis), [MONDO:0016358](http://purl.obolibrary.org/obo/MONDO_0016358) (limited cutaneous systemic sclerosis), [MONDO:0019159](http://purl.obolibrary.org/obo/MONDO_0019159) (Loeffler endocarditis), [MONDO:0019564](http://purl.obolibrary.org/obo/MONDO_0019564) (systemic sclerosis), [MONDO:0019158](http://purl.obolibrary.org/obo/MONDO_0019158) (tropical endomyocardial fibrosis), [MONDO:0009169](http://purl.obolibrary.org/obo/MONDO_0009169) (endocardial fibroelastosis), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0019563](http://purl.obolibrary.org/obo/MONDO_0019563) (crest syndrome), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0011895](http://purl.obolibrary.org/obo/MONDO_0011895) (idiopathic hypereosinophilic syndrome), [MONDO:0017835](http://purl.obolibrary.org/obo/MONDO_0017835) (lymphocytic hypereosinophilic syndrome), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), 

**Corr. equiv. classes:** [Orphanet:85445](http://www.orpha.net/ORDO/Orphanet_85445), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [OMIM:226000](http://purl.obolibrary.org/obo/OMIM_226000), [Orphanet:220393](http://www.orpha.net/ORDO/Orphanet_220393), [Orphanet:2022](http://www.orpha.net/ORDO/Orphanet_2022), [Orphanet:797](http://www.orpha.net/ORDO/Orphanet_797), [Orphanet:330001](http://www.orpha.net/ORDO/Orphanet_330001), [Orphanet:314970](http://www.orpha.net/ORDO/Orphanet_314970), [Orphanet:314950](http://www.orpha.net/ORDO/Orphanet_314950), [Orphanet:3260](http://www.orpha.net/ORDO/Orphanet_3260), [OMIM:181000](http://purl.obolibrary.org/obo/OMIM_181000), [Orphanet:90290](http://www.orpha.net/ORDO/Orphanet_90290), [Orphanet:90291](http://www.orpha.net/ORDO/Orphanet_90291), [OMIM:612387](http://purl.obolibrary.org/obo/OMIM_612387), [Orphanet:314709](http://www.orpha.net/ORDO/Orphanet_314709), [OMIM:612388](http://purl.obolibrary.org/obo/OMIM_612388), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:220407](http://www.orpha.net/ORDO/Orphanet_220407), [OMIM:607685](http://purl.obolibrary.org/obo/OMIM_607685), [OMIM:181750](http://purl.obolibrary.org/obo/OMIM_181750), [Orphanet:314701](http://www.orpha.net/ORDO/Orphanet_314701), [Orphanet:75565](http://www.orpha.net/ORDO/Orphanet_75565), [OMIM:609464](http://purl.obolibrary.org/obo/OMIM_609464), [Orphanet:75566](http://www.orpha.net/ORDO/Orphanet_75566), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), [Orphanet:220402](http://www.orpha.net/ORDO/Orphanet_220402), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 26.84%
- Thing 26.83%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 26.83%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 26.37%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 24.29%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 23.41%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 20.99%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 20.19%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 20.19%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) 19.55%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 18.62%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 18.34%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 17.81%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 17.44%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 15.82%


